CoreValve to Host 'ReValving(TM) Update' Conference Call: Thursday, November 17, 11:00 A.M. (EST).IRVINE, Calif., and PARIS Paris, in Greek mythology Paris or Alexander, in Greek mythology, son of Priam and Hecuba and brother of Hector. Because it was prophesied that he would cause the destruction of Troy, Paris was abandoned on Mt. -- CoreValve announced today that it will host a conference call on Thursday, November 17, at 11:00 A.M. (EST EST electroshock therapy. EST abbr. electroshock therapy ), 8:00 A.M. (PST PST Paroxysmal supraventricular tachycardia, see there ) and 17:00 (CEST). The purpose of the conference call will be to update the progress of CoreValve's ReValving(TM) approach to percutaneous aortic valve replacement In percutaneous aortic valve replacement (PAVR), a synthetic valve is transported to the heart through a small hole made in groin. This procedure can be compared to that performed when placing a stent, or performing balloon angioplasty. (PAVR). The call will be hosted by Jacques Seguin, M.D., Ph.D., Chairman, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. and Founder of CoreValve. Also participating in the conference call will be Rob Michiels, President of CoreValve USA. Approximately 10 minutes before the start of the call, interested parties who wish to participate "live" should dial +1-415-537-1849 and cite reservation number 21266940. In addition, the conference call will be audiostreamed "live" at www.corevalve.com. For those unable to participate "live", a recording of the conference call will be available from 1:00 P.M. (EST), November 17, 2005, until 1:00 P.M. (EST), November 18, 2005. Callers should dial +1-402-977-9140 and cite reservation number 21266940. About CoreValve Privately held CoreValve, with U.S. headquarters in Irvine, Calif., has developed a proprietary delivery system for percutaneous aortic heart valve replacement Heart Valve Replacement Definition Heart valve replacement is a surgical procedure during which surgeons remove a damaged valve from the heart and substitute a healthy one. (PAVR), based on a novel catheter-and-self-expanding-frame approach on a beating heart, thus avoiding open-heart surgery. The CoreValve procedure--with the proprietary CoreValve Percutaneous ReValving(TM) System--can be performed in a cardiac "cath lab" just like angioplasty and stenting, resulting in less trauma to the patient and substantial cost-savings to the healthcare system. For more information about CoreValve, visit the Company's Web site at www.corevalve.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion